Top compounds associated with response to PNPO


Feature Type Standardized
Nominal ANOVA
mRNA lenvatinib CTRPv2 pan-cancer AAC -0.046 0.2
mRNA AT7867 CTRPv2 pan-cancer AAC -0.044 0.2
mRNA CR-1-31B CTRPv2 pan-cancer AAC -0.04 0.2
mRNA Topotecan CTRPv2 pan-cancer AAC -0.039 0.2
mRNA BRD-K02251932 CTRPv2 pan-cancer AAC 0.047 0.2
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.04 0.2
mRNA nelarabine CTRPv2 pan-cancer AAC -0.047 0.2
mRNA STF-31 CTRPv2 pan-cancer AAC -0.043 0.2
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.046 0.2
mRNA erastin CTRPv2 pan-cancer AAC -0.042 0.2
Download CSV